Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 25, 2026

AI Search Startup Exa Labs Raises $250M At $2.2 Billion Valuation, Led By Andreessen Horowitz

View original at finance.yahoo.com
AI Search Startup Exa Labs Raises $250M At $2.2 Billion Valuation, Led By Andreessen Horowitz Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • AI-driven search demand will surge as more autonomous agents come online.

    60% confidence
  • Exa's search tools are used by more than 400,000 developers.

    60% confidence
  • Competitors built on top of existing search engines will struggle to match Exa's combination of speed, cost efficiency, and retrieval quality.

    60% confidence
  • Exa's crawlers index more than 500 billion URLs and the company has developed its own vector database to support high query volumes.

    60% confidence
  • Building a perfect search engine will be extremely hard. It is also necessary. Information is critical civilizational infrastructure for our new AI reality. If we can build perfect search so that every AI has the highest quality information, then every human will too.

    60% confidence
  • Different AI agents require different retrieval behavior — from go-to-market tools needing broad coverage of people and organizations, to coding assistants relying on precise results from repositories and technical documentation.

    60% confidence
  • Exa Labs usage has grown to more than 5,000 businesses since pivoting to an API-first model in early 2023.

    60% confidence
  • Exa Labs will use new capital to train its next generation of models and expand infrastructure capable of handling hundreds of thousands of searches per second.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
AI Search Startup Exa Labs Raises $250M At $2.2 Billion Valuation, Led By Andreessen Horowitz — Source | Via News | Via News